Richard R. Kerr
Three-marker test that improves on PSA now available
The University of Michigan Health System said it has begun offering a new urine test for prostate cancer that incorporates three specific markers for the disease, and studies have shown that the combination is significantly more accurate than the PSA test alone.
PSA does more harm than good: European analysis
In the latest examination of population-based screening for prostate cancer, French researchers say PSA testing does more harm than good.
Dr. Walsh joins ASTRO in denouncing self-referral
In its push to close the loophole on physician self-referral for prostate cancer treatment, the American Society for Radiation Oncology now has what some may call an unlikely ally.
Environmental toxins harm fertility, prostate health
Toxic chemicals in the environment harm our ability to reproduce and are associated with poor semen quality and prostate cancer, among other long-term health problems, according to the American College of Obstetricians and Gynecologists and the American Society for Reproductive Medicine.
Short-term as good as long-term hormonal therapy
Short-term hormone therapy appears to produce outcomes that are as favorable as those for long-term therapy in men with intermediate-risk prostate cancer, according to the results of two studies from the Radiation Therapy Oncology Group.
Dr. Snyder awarded Urology Medal
Urology Times congratulates Howard M. Snyder, III, MD, who received the Urology Medal at the recently concluded Pediatric Urology Fall Congress in Las Vegas. The Urology Medal is given to an individual who has made outstanding contributions to the field of pediatric urology.
LUGPA urges CMS to reject outpatient payment caps
A proposed rule from the Centers for Medicare & Medicaid Services that would cap payments for more than 200 physician services at outpatient prospective payment system or ambulatory surgery center rates would threaten patient access to optimal, cost-effective health care, according to the Large Urology Group Practice Association.
Study: PSA screening declining in post-USPSTF era
New research shows a significant decrease in PSA screening by primary care physicians since the release of the United States Preventive Services Task Force recommendation against screening in May 2012.
LUGPA position aims to clarify prostate cancer screening
In an attempt to clarify what it calls conflicting guideline statements on prostate cancer screening from various organizations, the Large Urology Group Practice Association has issued its own position on the use of the PSA test as a screening tool.
Lift device for BPH earns FDA approval
The FDA has authorized the marketing of the UroLift system, the first permanent implant to relieve low or blocked urine flow in men aged 50 years and older with BPH.

Poll

View Results